Mark Cuban Cost Plus Drug Company

Mark Cuban Cost Plus Drug Company (MCCPDC) is a public-benefit corporation founded in 2022 with a mission to disrupt the pharmaceutical industry by providing transparent, affordable access to generic and select brand-name medications. By bypassing traditional pharmacy benefit managers (PBMs) and wholesalers, the company employs a cost-plus pricing model—manufacturer acquisition cost plus a fixed 15% markup, a $5 pharmacy service fee, and a $5.25 shipping fee. Headquartered in Dallas, Texas, the company operates its own sterile fill-finish manufacturing facility and has built a vast catalog of over 2,300 medications. It actively partners with health plans, employers, and pharmacy networks to expand its reach, aiming to reduce drug spending and improve transparency across the U.S. healthcare system.